<DOC>
	<DOCNO>NCT00329901</DOCNO>
	<brief_summary>Immunogenicity Safety Concomitant Administration Tdap Vaccine Meningococcal ACWY Conjugate Vaccine Healthy Subjects Aged 11-25 Years</brief_summary>
	<brief_title>Immunogenicity Safety Concomitant Administration Tdap Vaccine Meningococcal ACWY Conjugate Vaccine Healthy Subjects Aged 11-25 Years</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Meningitis , Meningococcal</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male female 1125 year old healthy subject ; receive primary immunization vaccine contain DT Tdap antigens T , Td , Tdap booster injection least 5 year prior study entry previous ascertain suspected disease cause N. meningitidis previously immunize meningococcal vaccine vaccine contain meningococcal antigen ( ) serious acute , chronic progressive disease history anaphylaxis , serious vaccine reaction , allergy vaccine component know suspected impairment/alteration immune function , either congenital acquire</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Meningitis</keyword>
	<keyword>healthy subject</keyword>
	<keyword>vaccine</keyword>
</DOC>